Bayview Pharmacy is pleased to provide a compounded formulation of Estradiol 5 Mcg/Dehydroepiandrosterone 3 mg in the form of a vaginal suppository. This solid dosage form is designed to be inserted into the vagina, where it dissolves or melts to release the medication. It is primarily used for the treatment of conditions such as vulvovaginal atrophy, menopause, postmenopausal osteoporosis, uterine fibroids, and hypoestrogenism.

The symptoms associated with these conditions, including vaginal dryness, hot flashes, and bone loss, can be significantly reduced with the use of this formulation. The combination of estradiol and dehydroepiandrosterone in this suppository works to restore the body's natural hormone balance, which can alleviate the symptoms of these conditions.

This compounded formulation serves as an effective treatment option for patients who are unable to take oral hormone replacement therapy or who are seeking an alternative to traditional hormone replacement therapy. It offers a safe and effective approach for those who prefer a more natural method of hormone replacement therapy.

If you have any questions about this compounded formulation of Estradiol 5 Mcg/Dehydroepiandrosterone 3 mg vaginal suppository or would like to learn more about how it can help treat your condition, please do not hesitate to contact us. Our team is dedicated to helping you find the best treatment option tailored to your individual needs.

Estradiol 5 mcg/Dehydroepiandrosterone 3 mg Vaginal Suppository is a compounded formulation designed for the treatment of various conditions related to hormonal imbalances in women. These conditions include vulvovaginal atrophy, menopause, postmenopausal osteoporosis, uterine fibroids, and hypoestrogenism. The formulation contains two key active ingredients: Estradiol and Dehydroepiandrosterone (DHEA).

Estradiol is a form of estrogen, a female hormone primarily produced by the ovaries. It plays a crucial role in managing symptoms associated with menopause, such as hot flashes and vaginal dryness. Estradiol also contributes to the overall health of the female reproductive system and helps maintain bone density, thereby reducing the risk of osteoporosis.

Dehydroepiandrosterone (DHEA) is a hormone produced by the adrenal glands. It also aids in alleviating menopausal symptoms like hot flashes and night sweats. Additionally, DHEA has been found to help reduce the risk of osteoporosis and uterine fibroids, further enhancing its therapeutic value in this formulation.

The combination of estradiol and DHEA in this vaginal suppository provides a comprehensive approach to managing the symptoms of vulvovaginal atrophy, menopause, postmenopausal osteoporosis, uterine fibroids, and hypoestrogenism. This formulation is designed to dissolve or melt once inserted into the vagina, allowing for local or systemic absorption of the medication.

It is important to note that this formulation should not be used by women who are pregnant or breastfeeding due to potential risks. Always consult with a healthcare provider before starting any new medication regimen. If you have any questions or concerns about this formulation, please consult with your healthcare provider or pharmacist.

Estradiol 5 mcg/Dehydroepiandrosterone 3 mg Vaginal Suppository is a specially compounded medication designed to address a range of conditions associated with menopause, postmenopausal osteoporosis, uterine fibroids, hypoestrogenism, and vulvovaginal atrophy. The formulation contains two active ingredients: estradiol and dehydroepiandrosterone.

Estradiol, a form of estrogen, works to alleviate menopausal symptoms such as hot flashes and night sweats. Dehydroepiandrosterone, on the other hand, is a hormone that helps to mitigate the symptoms of postmenopausal osteoporosis, including bone loss and fractures.

The combination of these two hormones in this formulation also aids in reducing the symptoms of uterine fibroids, which can include heavy menstrual bleeding and pelvic pain. Furthermore, this combination is effective in addressing hypoestrogenism symptoms, such as vaginal dryness and hot flashes.

Lastly, the Estradiol 5 mcg/Dehydroepiandrosterone 3 mg Vaginal Suppository is beneficial in managing symptoms of vulvovaginal atrophy, which can include vaginal dryness, itching, and burning. This medication is typically administered vaginally, usually once daily.

If you have any questions or concerns about this formulation, please do not hesitate to reach out for further information.

This compounded formulation of Estradiol 5 Mcg/Dehydroepiandrosterone 3 mg Vaginal Suppository is a solid dosage form designed for insertion into the vagina. Upon insertion, it dissolves or melts, releasing the medication for local or systemic absorption. This formulation is primarily used to treat a variety of conditions. It can be used to manage hypoactive sexual desire disorder (HSDD) in postmenopausal women, a condition characterized by a decrease in sexual desire. It can also be used to treat androgen deficiency in women, a hormonal imbalance that can lead to a variety of symptoms including fatigue, weight gain, and mood changes.

In addition to these uses, this formulation can also be used to manage premenstrual dysphoric disorder (PMDD), a severe form of premenstrual syndrome that can cause significant physical and psychological distress. Furthermore, it can be used to reduce the risk of endometrial hyperplasia, a condition characterized by the thickening of the lining of the uterus, in postmenopausal women with an intact uterus who are receiving estrogen therapy.

Lastly, this formulation can also be used to reduce the risk of recurrent urinary tract infections in postmenopausal women. Urinary tract infections are common in postmenopausal women due to changes in the urinary tract and a decrease in estrogen levels. If you have any questions about the use of this formulation for any of these conditions, please do not hesitate to reach out for further information.